Denti.AI Receives FDA Clearance for AI Auto-Charting Software

Dentai.AI Auto-Chart, an artificial intelligence (AI)-powered software developed by Denti.AI, has received clearance from the US Food and Drug Administration (FDA). The device can assist dental professionals in interpreting intraoral and extraoral 2D x-ray images by detecting and numbering teeth and missing teeth. It also aids in the detection of dental structures added through past restorative treatment, such as implants, crowns, pontics, endodontic treatment, and fillings, as well as their attributes and affected surfaces.

Auto-Chart is designed to integrate directly with any practice management and imaging software system, creating seamless workflows for dental professionals. By automating the data entry process, Denti.AI Auto-Chart produces highly accurate and complete patient charts. While studying its efficacy, the FDA found that Auto-Chart demonstrated a 70% reduction in time and effort required to create dental charts, according to a press release from Denti.AI.

Denti.AI Auto-Chart’s quick and reliable imaging-based odontogram-charting complements Denti.AI Voice, which is used to improve the speed and accuracy of perio charting. Combined, these products drive better patient outcomes and bottom-line growth.

Denti.AI recently closed a pre-Series A round of funding on this patented technology. Practices and DSOs can enroll in a trial version of Auto-Chart on the company’s website.